It was a time for Mylan NV and the US FDA to celebrate, as the agency gave its first ever blessing to a generic of the hard-to-copy Advair Diskus (fluticasone propionate and salmeterol inhalation powder). Advair Diskus, along with EpiPen (epinephrine injection), have long epitomized the difficulties of copying complex products.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?